ANLN | Anillin, actin binding protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
APBB3 | Amyloid beta (A4) precursor protein-binding, family B, member 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
CAMKK1 | Calcium/calmodulin-dependent protein kinase kinase 1, alpha | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDK5R1 | Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CRMP1 | Collapsin response mediator protein 1 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
EYA1 | EYA transcriptional coactivator and phosphatase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM169A | Family with sequence similarity 169, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM189A1 | Family with sequence similarity 189, member A1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPRC5B | G protein-coupled receptor, class C, group 5, member B | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRIA3 | Glutamate receptor, ionotropic, AMPA 3 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
KLHL35 | Kelch-like family member 35 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
L1CAM | L1 cell adhesion molecule | CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMP5 | Lysosomal-associated membrane protein family, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NAP1L2 | Nucleosome assembly protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NOVA1 | Neuro-oncological ventral antigen 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NTRK3 | Neurotrophic tyrosine kinase, receptor, type 3 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NUAK1 | NUAK family, SNF1-like kinase, 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NYAP1 | Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPM1E | Protein phosphatase, Mg2+/Mn2+ dependent, 1E | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRR | Protein tyrosine phosphatase, receptor type, R | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RGMA | Repulsive guidance molecule family member a | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RNF157 | Ring finger protein 157 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF165 | Ring finger protein 165 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF208 | Ring finger protein 208 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RTBDN | Retbindin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RTN4R | Reticulon 4 receptor | Predicted membrane proteins
| | | | | Tissue enhanced |
SEPT4 | Septin 4 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SH2D5 | SH2 domain containing 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC25A22 | Solute carrier family 25 (mitochondrial carrier: glutamate), member 22 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SPTBN2 | Spectrin, beta, non-erythrocytic 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SSTR2 | Somatostatin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SV2C | Synaptic vesicle glycoprotein 2C | Predicted membrane proteins
| | | | | Tissue enhanced |
SYT13 | Synaptotagmin XIII | Predicted intracellular proteins
| | | | | Tissue enhanced |
SYT2 | Synaptotagmin II | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TCEAL7 | Transcription elongation factor A (SII)-like 7 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TREM2 | Triggering receptor expressed on myeloid cells 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ZIC1 | Zic family member 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |